Showing results (71-80 of 10,913) with videos related to
Sort By:
Pageof 1,092
Breast Cancer Research and Treatment|October 8, 2017
Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impactDavid B Page, Hannah Wen, Edi Brogi, et al.The Oncologist|January 4, 2019
Phase II Study of Weekly Paclitaxel with Trastuzumab and Pertuzumab in Patients with Human Epidermal Growth Receptor 2 Overexpressing Metastatic Breast Cancer: 5-Year Follow-upRui Wang, Lillian M Smyth, Neil Iyengar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-upLee K Tan, Dilip Giri, Amanda J Hummer, et al.Seminars in Oncology|November 28, 1997
Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancerA D Seidman, C A Hudis, J McCaffrey, et al.Clinical Advances in Hematology & Oncology : H&O|July 9, 2011
Recent advances in the treatment of breast cancer: highlights from the 2010 San Antonio Breast Cancer SymposiumEdith Perez, Harold J Burstein, Clifford HudisMolecular Oncology|August 25, 2014
Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective studyLeonardo Tenori, Catherine Oakman, Patrick G Morris, et al.Journal of the National Cancer Institute|December 22, 1999
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutationsM Robson, D Levin, M Federici, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2012
Frequent mutational activation of the PI3K-AKT pathway in trastuzumab-resistant breast cancerSarat Chandarlapaty, Rita A Sakr, Dilip Giri, et al.Oncogene|October 27, 2009
Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growthS Chandarlapaty, M Scaltriti, P Angelini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 21, 2007
Toxicity of older and younger patients treated with adjuvant chemotherapy for node-positive breast cancer: the Cancer and Leukemia Group B ExperienceHyman B Muss, Donald A Berry, Constance Cirrincione, et al.Pageof 1,092